1. Project
  2. CureGLIO
  3. Organisations

Clinical validation of GLIX1: a small molecule that targets epigenetic changes in cancer cells to treat glioblastoma multiforme (GBM), the highest global unmet need in oncology.

Full project page

Organisations map overview


Powered by Chris Decubber BV